HEADER TRANSFERASE/TRANSFERASE INHIBITOR 18-MAR-19 6OAV TITLE JAK2 JH2 IN COMPLEX WITH JAK146 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: JANUS KINASE 2,JAK-2; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PSEUDOKINASE DOMAIN, INHIBITOR, COMPLEX, TRANSFERASE, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.G.KRIMMER,M.E.LIOSI,D.E.PULEO,J.SCHLESSINGER,W.L.JORGENSEN REVDAT 3 11-OCT-23 6OAV 1 REMARK REVDAT 2 28-APR-21 6OAV 1 JRNL REVDAT 1 25-MAR-20 6OAV 0 JRNL AUTH M.E.LIOSI,S.G.KRIMMER,A.S.NEWTON,T.K.DAWSON,D.E.PULEO, JRNL AUTH 2 K.J.CUTRONA,Y.SUZUKI,J.SCHLESSINGER,W.L.JORGENSEN JRNL TITL SELECTIVE JANUS KINASE 2 (JAK2) PSEUDOKINASE LIGANDS WITH A JRNL TITL 2 DIAMINOTRIAZOLE CORE. JRNL REF J.MED.CHEM. V. 63 5324 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 32329617 JRNL DOI 10.1021/ACS.JMEDCHEM.0C00192 REMARK 2 REMARK 2 RESOLUTION. 1.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.11.1_2575: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.34 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.410 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 20922 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1048 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 41.3527 - 3.7087 0.98 2893 153 0.1600 0.1798 REMARK 3 2 3.7087 - 2.9439 0.99 2869 151 0.1849 0.2379 REMARK 3 3 2.9439 - 2.5719 1.00 2872 151 0.2033 0.2276 REMARK 3 4 2.5719 - 2.3367 1.00 2852 150 0.1999 0.2747 REMARK 3 5 2.3367 - 2.1693 0.98 2817 149 0.2217 0.2778 REMARK 3 6 2.1693 - 2.0414 0.99 2818 148 0.2702 0.3154 REMARK 3 7 2.0414 - 1.9391 0.96 2753 146 0.4696 0.4815 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.710 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2128 REMARK 3 ANGLE : 0.775 2902 REMARK 3 CHIRALITY : 0.051 330 REMARK 3 PLANARITY : 0.005 376 REMARK 3 DIHEDRAL : 13.858 1251 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6OAV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-MAR-19. REMARK 100 THE DEPOSITION ID IS D_1000240316. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUL-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20958 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.939 REMARK 200 RESOLUTION RANGE LOW (A) : 200.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10300 REMARK 200 FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.06 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.87200 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5USZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS, PH 8.0 0.2M SODIUM ACETATE, REMARK 280 0.001 M TCEP, 12-24% PEG 4,000, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 28.67800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 536 REMARK 465 PHE A 809 REMARK 465 THR A 810 REMARK 465 PRO A 811 REMARK 465 ASP A 812 REMARK 465 LEU A 813 REMARK 465 VAL A 814 REMARK 465 PRO A 815 REMARK 465 ARG A 816 REMARK 465 GLY A 817 REMARK 465 SER A 818 REMARK 465 HIS A 819 REMARK 465 HIS A 820 REMARK 465 HIS A 821 REMARK 465 HIS A 822 REMARK 465 HIS A 823 REMARK 465 HIS A 824 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 539 CG CD CE NZ REMARK 470 ARG A 541 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 543 CG CD OE1 OE2 REMARK 470 LYS A 558 CE NZ REMARK 470 ARG A 565 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 572 CG CD OE1 NE2 REMARK 470 GLU A 575 CG CD OE1 OE2 REMARK 470 LYS A 585 CG CD CE NZ REMARK 470 ARG A 588 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 592 CG CD OE1 OE2 REMARK 470 GLU A 596 CG CD OE1 OE2 REMARK 470 MET A 600 CG SD CE REMARK 470 LYS A 603 CG CD CE NZ REMARK 470 LYS A 630 CD CE NZ REMARK 470 LYS A 639 CG CD CE NZ REMARK 470 LYS A 640 CG CD CE NZ REMARK 470 LYS A 642 CE NZ REMARK 470 ASN A 643 CG OD1 ND2 REMARK 470 CYS A 644 SG REMARK 470 ILE A 647 CD1 REMARK 470 LEU A 648 CG CD1 CD2 REMARK 470 LYS A 677 CD CE NZ REMARK 470 ASP A 686 CG OD1 OD2 REMARK 470 ARG A 687 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 688 CG CD CE NZ REMARK 470 THR A 689 OG1 CG2 REMARK 470 LYS A 709 NZ REMARK 470 GLU A 725 CD OE1 OE2 REMARK 470 LYS A 728 CD CE NZ REMARK 470 GLN A 760 CG CD OE1 NE2 REMARK 470 GLU A 767 CD OE1 OE2 REMARK 470 ARG A 769 NE CZ NH1 NH2 REMARK 470 LYS A 776 CG CD CE NZ REMARK 470 ARG A 799 CD NE CZ NH1 NH2 REMARK 470 ARG A 803 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 804 CG OD1 OD2 REMARK 470 LEU A 808 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 548 -137.84 -114.52 REMARK 500 CYS A 644 -5.86 -167.25 REMARK 500 ASN A 673 58.36 -150.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue M3A A 901 DBREF 6OAV A 536 812 UNP O60674 JAK2_HUMAN 536 812 SEQADV 6OAV ALA A 659 UNP O60674 TRP 659 ENGINEERED MUTATION SEQADV 6OAV ALA A 777 UNP O60674 TRP 777 ENGINEERED MUTATION SEQADV 6OAV HIS A 794 UNP O60674 PHE 794 ENGINEERED MUTATION SEQADV 6OAV LEU A 813 UNP O60674 EXPRESSION TAG SEQADV 6OAV VAL A 814 UNP O60674 EXPRESSION TAG SEQADV 6OAV PRO A 815 UNP O60674 EXPRESSION TAG SEQADV 6OAV ARG A 816 UNP O60674 EXPRESSION TAG SEQADV 6OAV GLY A 817 UNP O60674 EXPRESSION TAG SEQADV 6OAV SER A 818 UNP O60674 EXPRESSION TAG SEQADV 6OAV HIS A 819 UNP O60674 EXPRESSION TAG SEQADV 6OAV HIS A 820 UNP O60674 EXPRESSION TAG SEQADV 6OAV HIS A 821 UNP O60674 EXPRESSION TAG SEQADV 6OAV HIS A 822 UNP O60674 EXPRESSION TAG SEQADV 6OAV HIS A 823 UNP O60674 EXPRESSION TAG SEQADV 6OAV HIS A 824 UNP O60674 EXPRESSION TAG SEQRES 1 A 289 VAL PHE HIS LYS ILE ARG ASN GLU ASP LEU ILE PHE ASN SEQRES 2 A 289 GLU SER LEU GLY GLN GLY THR PHE THR LYS ILE PHE LYS SEQRES 3 A 289 GLY VAL ARG ARG GLU VAL GLY ASP TYR GLY GLN LEU HIS SEQRES 4 A 289 GLU THR GLU VAL LEU LEU LYS VAL LEU ASP LYS ALA HIS SEQRES 5 A 289 ARG ASN TYR SER GLU SER PHE PHE GLU ALA ALA SER MET SEQRES 6 A 289 MET SER LYS LEU SER HIS LYS HIS LEU VAL LEU ASN TYR SEQRES 7 A 289 GLY VAL CYS VAL CYS GLY ASP GLU ASN ILE LEU VAL GLN SEQRES 8 A 289 GLU PHE VAL LYS PHE GLY SER LEU ASP THR TYR LEU LYS SEQRES 9 A 289 LYS ASN LYS ASN CYS ILE ASN ILE LEU TRP LYS LEU GLU SEQRES 10 A 289 VAL ALA LYS GLN LEU ALA ALA ALA MET HIS PHE LEU GLU SEQRES 11 A 289 GLU ASN THR LEU ILE HIS GLY ASN VAL CYS ALA LYS ASN SEQRES 12 A 289 ILE LEU LEU ILE ARG GLU GLU ASP ARG LYS THR GLY ASN SEQRES 13 A 289 PRO PRO PHE ILE LYS LEU SER ASP PRO GLY ILE SER ILE SEQRES 14 A 289 THR VAL LEU PRO LYS ASP ILE LEU GLN GLU ARG ILE PRO SEQRES 15 A 289 TRP VAL PRO PRO GLU CYS ILE GLU ASN PRO LYS ASN LEU SEQRES 16 A 289 ASN LEU ALA THR ASP LYS TRP SER PHE GLY THR THR LEU SEQRES 17 A 289 TRP GLU ILE CYS SER GLY GLY ASP LYS PRO LEU SER ALA SEQRES 18 A 289 LEU ASP SER GLN ARG LYS LEU GLN PHE TYR GLU ASP ARG SEQRES 19 A 289 HIS GLN LEU PRO ALA PRO LYS ALA ALA GLU LEU ALA ASN SEQRES 20 A 289 LEU ILE ASN ASN CYS MET ASP TYR GLU PRO ASP HIS ARG SEQRES 21 A 289 PRO SER PHE ARG ALA ILE ILE ARG ASP LEU ASN SER LEU SEQRES 22 A 289 PHE THR PRO ASP LEU VAL PRO ARG GLY SER HIS HIS HIS SEQRES 23 A 289 HIS HIS HIS HET M3A A 901 24 HETNAM M3A 5-AMINO-3-[(4-CYANOPHENYL)AMINO]-N-PHENYL-1H-1,2,4- HETNAM 2 M3A TRIAZOLE-1-CARBOXAMIDE FORMUL 2 M3A C16 H13 N7 O FORMUL 3 HOH *103(H2 O) HELIX 1 AA1 ARG A 541 GLU A 543 5 3 HELIX 2 AA2 ASP A 569 GLY A 571 5 3 HELIX 3 AA3 LYS A 585 ASN A 589 5 5 HELIX 4 AA4 TYR A 590 LEU A 604 1 15 HELIX 5 AA5 SER A 633 ASN A 641 1 9 HELIX 6 AA6 LYS A 642 ILE A 645 5 4 HELIX 7 AA7 ASN A 646 ASN A 667 1 22 HELIX 8 AA8 CYS A 675 LYS A 677 5 3 HELIX 9 AA9 ASP A 686 GLY A 690 5 5 HELIX 10 AB1 PRO A 708 ARG A 715 1 8 HELIX 11 AB2 PRO A 720 ASN A 726 1 7 HELIX 12 AB3 PRO A 727 LEU A 730 5 4 HELIX 13 AB4 ASN A 731 SER A 748 1 18 HELIX 14 AB5 ASP A 758 ASP A 768 1 11 HELIX 15 AB6 ALA A 777 GLU A 779 5 3 HELIX 16 AB7 LEU A 780 MET A 788 1 9 HELIX 17 AB8 GLU A 791 ARG A 795 5 5 HELIX 18 AB9 SER A 797 LEU A 808 1 12 SHEET 1 AA1 5 LEU A 545 GLY A 554 0 SHEET 2 AA1 5 THR A 557 VAL A 567 -1 O ILE A 559 N LEU A 551 SHEET 3 AA1 5 LEU A 573 LEU A 583 -1 O HIS A 574 N GLU A 566 SHEET 4 AA1 5 ILE A 623 GLU A 627 -1 O GLN A 626 N LEU A 579 SHEET 5 AA1 5 ASN A 612 CYS A 616 -1 N GLY A 614 O VAL A 625 SHEET 1 AA2 2 ILE A 679 ARG A 683 0 SHEET 2 AA2 2 PHE A 694 LEU A 697 -1 O LYS A 696 N LEU A 680 CISPEP 1 ILE A 716 PRO A 717 0 8.80 SITE 1 AC1 13 ILE A 559 LEU A 579 LYS A 581 GLN A 626 SITE 2 AC1 13 GLU A 627 PHE A 628 VAL A 629 LYS A 630 SITE 3 AC1 13 GLY A 632 LYS A 677 ASN A 678 LEU A 680 SITE 4 AC1 13 SER A 698 CRYST1 44.123 57.356 60.744 90.00 110.45 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022664 0.000000 0.008449 0.00000 SCALE2 0.000000 0.017435 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017569 0.00000